14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of UNCY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Unicycive Therapeutics, Inc. stock price down 1.32% on Thursday
(Updated on May 02, 2024)

Sell candidate since Apr 12, 2024 Loss -8.20% PDF

The Unicycive Therapeutics, Inc. stock price fell by -1.32% on the last day (Thursday, 2nd May 2024) from $1.14 to $1.12. During the last trading day the stock fluctuated 6.36% from a day low at $1.10 to a day high of $1.17. The price has fallen in 6 of the last 10 days but is still up by 2.75% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -31 thousand shares and in total, 238 thousand shares were bought and sold for approximately $266.97 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.65% during the next 3 months and, with a 90% probability hold a price between $0.84 and $1.43 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

UNCY Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 15.46%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Unicycive Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.28. On a fall, the stock will find some support from the short-term average at $1.09. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Unicycive Therapeutics, Inc. stock

Unicycive Therapeutics, Inc. finds support from accumulated volume at $1.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0700 between high and low, or 6.36%. For the last week the stock has had daily average volatility of 12.47%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UNCY) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Unicycive Therapeutics, Inc. to open at $1.13, and during the day (based on 14 day Average True Range), to move between $1.00 and $1.24, which gives a possible trading interval of +/-$0.117 (+/-10.45%) up or down from last closing price. If Unicycive Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 20.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.14 (1.79%) than the support at $1.09 (2.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Unicycive Therapeutics, Inc. stock A Buy?

Unicycive Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.971 Sell Candidate Unchanged

Predicted Opening Price for Unicycive Therapeutics, Inc. of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$1.13 ( 0.89%) $1.12

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for UNCY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.20 7.14 %
R2 1.17 4.76 %
R1 1.16 3.28 %
Current price: 1.12
Support S1 1.10 -1.49 %
S2 1.09 -2.97 %
S3 1.06 -5.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.38 23.21 %
R2 1.22 8.93 %
R1 1.14 1.79 %
Current price 1.12
Support S1 1.09 -2.68%
S2 1.07 -4.46%
S3 0.97 -13.39%

FAQ

What is the symbol for Unicycive Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Unicycive Therapeutics, Inc. is UNCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Unicycive Therapeutics, Inc. Stock?
Unicycive Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Unicycive Therapeutics, Inc. Stock?
Unicycive Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Unicycive Therapeutics, Inc. Stock.

What's the current price of Unicycive Therapeutics, Inc. Stock?
As of the end of day on the May 02, 2024, the price of an Unicycive Therapeutics, Inc. (UNCY) share was $1.12.

What is the 52-week high and low for Unicycive Therapeutics, Inc. Stock?
The 52-week high for Unicycive Therapeutics, Inc. Stock is $1.82 and the 52-week low is $0.470.

What is the market capitalization of Unicycive Therapeutics, Inc. Stock?
As of the May 02, 2024, the market capitalization of Unicycive Therapeutics, Inc. is 38.927M.

When is the next earnings date for Unicycive Therapeutics, Inc.?
The upcoming earnings date for Unicycive Therapeutics, Inc. is May 21, 2024.
Click to get the best stock tips daily for free!

About Unicycive Therapeutics, Inc.

Unicycive Therapeutics. Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.... UNCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT